Mylan Technologies Inc.
$1.3M 0 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Turing Medical Technologies
Turing Medical Technologies reported $1,283,039.18 across General Payments, Research, and Ownership to 37 physicians and teaching hospitals across 38 transactions.
- $1.3M
- All-tracks total
- 38
- Transactions
- 37
- Recipients
- +$22.9K
- General Payments vs PY2023
Turing Medical Technologies reported $1,283,039.18 across all CMS Open Payments tracks (General + Research + Ownership) to 37 physicians and teaching hospitals in Program Year 2024 - ranking #562 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $128,319.98, averaging $34.7K per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer turing-medical-technologies Turing Medical Technologies
$1.3M · #562/1,925 · 0.0% industry · PY2024
- TOT $1.3M
- RANK #562
- SHARE 0.0%
- TXN 38
- RCP 37
- CAT 2
- GEN $128.3K
- ΔGEN +$22.9K
- TOP1 38.0%
- PY 2024
Volume peers
Nearest volume peer: Mylan Technologies Inc. ($1.3M)
Turing Medical Technologies sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Turing Medical Technologies's CMS-reported General Payments increased by $22.9K (+21.7%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2023: TURING MEDICAL TECHNOLOGIESPY2024: Turing Medical Technologies. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $105,439.70
- PY2024
- $128,319.98
What the Data Shows for Turing Medical Technologies
Averaging $33.8K per transaction and $34.7K per recipient, Turing Medical Technologies's Program Year 2024 total comes to $1,283,039.18 across 38 transactions and 37 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #562 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
Of the 2 general-payment categories charted below, "Consulting Fee" is the largest at $123.4K across 35 transactions, 96.1% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 2 types of general payments, Turing Medical Technologies's largest category was "Consulting Fee" at $123.4K - 96.1% of General Payments.
How Turing Medical Technologies divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $123.4K | 35 | 96.1% |
| Travel and Lodging | $4.9K | 2 | 3.9% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $90,804.35 (70.8%) of $128,319.98 in this company's General Payments records across 16 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Turing Medical Technologies
The five named recipients with the highest reported General Payments from this company
- 1
Nico Dosenbach
$48,721.65 across 3 reported transactions
- 2
Leo Sugrue
$16,682.70 across 3 reported transactions
- 3
Lawrence Tanenbaum
$9,000.00 across 12 reported transactions
- 4
James Anderson
$8,400.00 across 1 reported transactions
- 5
Brian Kopell
$8,000.00 across 5 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Turing Medical Technologies's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Turing Medical Technologies.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Turing Medical Technologies.
Showing 6 of 1,924 companies with CMS-reported payment data.
Berlin Heart Inc
$1.3M 103 recipients
Compare payment profiles
Sonendo Inc
$1.3M 3,307 recipients
Compare payment profiles
Ingeniumspine, LLC
$1.3M 21 recipients
Compare payment profiles
Smisson-Cartledge Biomedical
$1.3M 0 recipients
Compare payment profiles
Hyhte Holdings Inc.
$1.3M 77 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.